14-28767840-C-G
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PS1PM1PM2PP2PP3_ModeratePP5_Very_Strong
The NM_005249.5(FOXG1):c.561C>G(p.Asn187Lys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Pathogenic in Lovd.
Frequency
Consequence
NM_005249.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXG1 | ENST00000313071.7 | c.561C>G | p.Asn187Lys | missense_variant | Exon 1 of 1 | 6 | NM_005249.5 | ENSP00000339004.3 | ||
FOXG1 | ENST00000706482.1 | c.561C>G | p.Asn187Lys | missense_variant | Exon 2 of 2 | ENSP00000516406.1 | ||||
LINC01551 | ENST00000675861.1 | n.374+1827C>G | intron_variant | Intron 1 of 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
- -
not provided Pathogenic:1
The N187K variant, resulting from a different nucleotide substitution (c.561 C>A), has been reported previously as a de novo variant in a patient referred for clinical whole exome sequencing (Farwell et al., 2015). Additionally, the N187K variant has been identified as a de novo variant in another patient with epilepsy at GeneDx. The N187K variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The N187K variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution alters a conserved position predicted to occur within the forkhead binding domain of the FOXG1 protein where all previously reported missense variants in FOXG1 have been identified. A different missense variant in the same codon (N187D) as well as missense variants in nearby residues (L189V, M191R) have been reported in the Human Gene Mutation Database in association with FOXG1-related disorders (Stenson et al., 2014). -
Rett syndrome, congenital variant Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on FOXG1 protein function. ClinVar contains an entry for this variant (Variation ID: 265363). This missense change has been observed in individual(s) with clinical features of FOXG1-related conditions (PMID: 28628100, 28661489). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 187 of the FOXG1 protein (p.Asn187Lys). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at